Navidea sells shares to raise funds for operations

01/30/2013 | Wall Street Journal, The

Navidea Biopharmaceuticals said it has sold 1.5 million shares to J.P. Morgan Chase & Co.'s asset management unit and an additional investor to raise money to support its operations while it waits for an FDA decision on its radiopharmaceutical agent Lymphoseek. Navidea expects a decision in April and is also pursuing European approval for the agent.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI